Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gertraud Orend

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2024
Targeting the MAtrix REgulating MOtif abolishes several hallmarks of cancer, triggering antitumor immunityChengbei Li, Amanpreet Kaur, Alexia Pavlidaki, et al.
JCI Insight|October 30, 2024
Granzyme B cleaves tenascin-C to release its C-terminal domain in rheumatoid arthritisAlexandre Aubert, Amy Liu, Martin Kao, et al.
Plos One|October 28, 2014
The laminin response in inflammatory bowel disease: protection or malignancy?Caroline Spenlé, Olivier Lefebvre, Joël Lacroute, et al.
Disease Models & Mechanisms|September 24, 2015
A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutationsMichael Buchert, Franziska Rohde, Moritz Eissmann, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|March 1, 2022
Modulating tenascin-C functions by targeting the MAtrix REgulating MOtif, "MAREMO"Thomas Loustau, Chérine Abou-Faycal, William Erne, et al.
International Journal of Molecular Sciences|May 13, 2023
Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2Martha Gschwandtner, Anís N Gammage, Claire Deligne, et al.
Frontiers in Immunology|July 22, 2021
Impact of Tenascin-C on Radiotherapy in a Novel Syngeneic Oral Squamous Cell Carcinoma Model With Spontaneous Dissemination to the Lymph NodesCaroline Spenlé, Thomas Loustau, Hélène Burckel, et al.
Cell Reports|September 16, 2014
Transmembrane domain targeting peptide antagonizing ErbB2/Neu inhibits breast tumor growth and metastasisAlexia Arpel, Paul Sawma, Caroline Spenlé, et al.
The Journal of Biological Chemistry|January 6, 2010
Mutations in Lama1 disrupt retinal vascular development and inner limiting membrane formationMalia M Edwards, Elmina Mammadova-Bach, Fabien Alpy, et al.
Frontiers in Immunology|April 1, 2021
Novel Human Tenascin-C Function-Blocking Camel Single Domain NanobodiesSayda Dhaouadi, Rahma Ben Abderrazek, Thomas Loustau, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2024
Targeting the MAtrix REgulating MOtif abolishes several hallmarks of cancer, triggering antitumor immunityChengbei Li, Amanpreet Kaur, Alexia Pavlidaki, et al.
JCI Insight|October 30, 2024
Granzyme B cleaves tenascin-C to release its C-terminal domain in rheumatoid arthritisAlexandre Aubert, Amy Liu, Martin Kao, et al.
Plos One|October 28, 2014
The laminin response in inflammatory bowel disease: protection or malignancy?Caroline Spenlé, Olivier Lefebvre, Joël Lacroute, et al.
Disease Models & Mechanisms|September 24, 2015
A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutationsMichael Buchert, Franziska Rohde, Moritz Eissmann, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|March 1, 2022
Modulating tenascin-C functions by targeting the MAtrix REgulating MOtif, "MAREMO"Thomas Loustau, Chérine Abou-Faycal, William Erne, et al.
International Journal of Molecular Sciences|May 13, 2023
Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2Martha Gschwandtner, Anís N Gammage, Claire Deligne, et al.
Frontiers in Immunology|July 22, 2021
Impact of Tenascin-C on Radiotherapy in a Novel Syngeneic Oral Squamous Cell Carcinoma Model With Spontaneous Dissemination to the Lymph NodesCaroline Spenlé, Thomas Loustau, Hélène Burckel, et al.
Cell Reports|September 16, 2014
Transmembrane domain targeting peptide antagonizing ErbB2/Neu inhibits breast tumor growth and metastasisAlexia Arpel, Paul Sawma, Caroline Spenlé, et al.
The Journal of Biological Chemistry|January 6, 2010
Mutations in Lama1 disrupt retinal vascular development and inner limiting membrane formationMalia M Edwards, Elmina Mammadova-Bach, Fabien Alpy, et al.
Frontiers in Immunology|April 1, 2021
Novel Human Tenascin-C Function-Blocking Camel Single Domain NanobodiesSayda Dhaouadi, Rahma Ben Abderrazek, Thomas Loustau, et al.
Pageof 7